- Home
- / Repare Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Repare Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.6
2024-10-29
Market Capitalization
$152.4 M
2024-10-29
Revenue
$53.5 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 135.0K | 7.6M | 131.8M | 51.1M | 53.5M | |
| Gross profit | 135.0K | 7.6M | 131.8M | 51.1M | 53.5M | |
| Gross profit margin, % | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Operating expense total | 25.8M | 53.5M | 114.8M | 149.6M | 165.4M | 145.1M |
| Depreciation and amortization | 606.0K | 897.0K | 1.5M | 2.0M | 2.0M | 1.9M |
| EBITDA | (25.8M) | (53.4M) | (107.2M) | (17.8M) | (114.3M) | (91.6M) |
| EBITDA margin, % | -39559.3% | -1410.4% | -13.5% | -223.5% | -171.3% | |
| EBIT | (27.7M) | (54.3M) | (108.7M) | (19.8M) | (116.3M) | (93.6M) |
| EBIT margin, % | -40235.6% | -1430.3% | -15.0% | -227.5% | -175.1% | |
| Interest income | 240.0K | 259.0K | 5.6M | 13.3M | 10.4M | |
| Pre tax profit | (27.0M) | (54.7M) | (108.6M) | (13.9M) | (103.2M) | (83.2M) |
| Income tax expense | 195.0K | (1.3M) | (1.7M) | 15.1M | (9.4M) | 1.4M |
| Net Income | (27.2M) | (53.4M) | (106.9M) | (29.0M) | (93.8M) | (84.7M) |